Sep 19 |
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
|
Sep 17 |
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
|
Sep 13 |
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
|
Sep 11 |
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
|
Jul 31 |
Russell 2000 rise: Top 5 best, worst performers during July's rally in small-cap stocks
|
Jul 26 |
The Junk in Your Index Fund Is Costing You Big-Time
|
Jun 14 |
Renovaro announces $10M in equity committed
|
Jun 14 |
Renovaro, Inc. Announces $10 million in Equity Committed
|
May 24 |
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
|
Apr 30 |
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
|